Corinthian Ewesuedo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Corinthian Ewesuedo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Colin K. Drummond
Case Western Reserve University, USA
1 shared publication - Ezimma Onwuka
Case Western Reserve University, USA
1 shared publication - Paul C. Bryson
Cleveland Clinic Lerner College of Medicine;Case Western Reserve University, USA
1 shared publication - Shreshtha Das
Case Western Reserve University, USA
1 shared publication - Tara Chatty
Case Western Reserve University, USA
1 shared publication - Waleed Shirwa
Case Western Reserve University, USA
1 shared publication
Latest Publications
- Open Access
- 29 May 2026
- Published by MDPI AG in Preprints.org
Pilot Study of Voice and Speech Biomarkers: Exploring Healthy Controls in a Non-Clinical Setting
Voice-based approaches for screening and diagnostic applications, particularly in telemedicine, often rely on patient recordings collected outside clinical environments. Establishing normative baselines is essential to advance voice analytics and clinical utility. This pilot study examined acoustic parameters in 32 healthy young adults (ages 18–24) with no history of vocal pathology, neurological disorders, or speech impediments. Recordings focused on sustained vowels (/a/, /e/, /o/, /u/) for the primary study of voice characteristics, and an exploratory speech study and a standardized phonetically balanced phrase. Analyses focused on features including fundamental frequency, jitter, shimmer, harmonics-to-noise ratio, formants (F1–F3), speaking rate, intensity, and spectral measures. Preliminary results revealed significant differences between healthy controls and a reference dataset of laryngitis patients, suggesting acoustic features can serve as objective markers of vocal fold inflammation. However, pathology-specific biomarker identification was constrained by the quality of available laryngitis data. Simple statistical comparisons proved insufficient, emphasizing the value of multivariate analysis, cepstral peak prominence (CPP), and mel-frequency cepstral coefficients (MFCC). Challenges in non-clinical data collection highlight the need for standardized, detailed annotation of patient recordings to improve diagnostic accuracy and strengthen the predictive power of future biomarker studies.
- 29 May 2026
- Published by MDPI AG in Preprints.org
Open AccessPilot Study of Voice and Speech Biomarkers: Exploring Healthy Controls in a Non-Clinical Setting
Voice-based approaches for screening and diagnostic applications, particularly in telemedicine, often rely on patient recordings collected outside clinical environments. Establishing normative baselines is essential to advance voice analytics and clinical utility. This pilot study examined acoustic parameters in 32 healthy young adults (ages 18–24) with no history of vocal pathology, neurological disorders, or speech impediments. Recordings focused on sustained vowels (/a/, /e/, /o/, /u/) for the primary study of voice characteristics, and an exploratory speech study and a standardized phonetically balanced phrase. Analyses focused on features including fundamental frequency, jitter, shimmer, harmonics-to-noise ratio, formants (F1–F3), speaking rate, intensity, and spectral measures. Preliminary results revealed significant differences between healthy controls and a reference dataset of laryngitis patients, suggesting acoustic features can serve as objective markers of vocal fold inflammation. However, pathology-specific biomarker identification was constrained by the quality of available laryngitis data. Simple statistical comparisons proved insufficient, emphasizing the value of multivariate analysis, cepstral peak prominence (CPP), and mel-frequency cepstral coefficients (MFCC). Challenges in non-clinical data collection highlight the need for standardized, detailed annotation of patient recordings to improve diagnostic accuracy and strengthen the predictive power of future biomarker studies.